Merit Medical Announces Results Of First-In-Human Study Of WRAPSODY Cell-Impermeable Endoprosthesis
Prospective, observational study published in CardioVascular and Interventional Radiology1 reports 100% target lesion primary patency ("TLPP") rate without reintervention through 30 days, with a